| Title
|
PubMed Id
|
Authors
|
Journal Abbreviation
|
Year
|
Studies
|
| Direct Prediction of Cardiovascular Mortality from Low-dose Chest CT using Deep Learning |
|
S. G. M. van Velzen, M. Zreik, N. Lessmann, M. A. Viergever, P. A. de Jong, H. M.
Verkooijen, and I. Išgum |
CoRR |
2018 |
NLST |
| Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation. |
30518460
|
Snowsill T, Yang H, Griffin E, Long L, Varley-Campbell J, Coelho H, Robinson S, Hyde C |
Health Technol Assess |
2018 |
NLST |
| Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? |
28339311
|
Chung K, Jacobs C, Scholten ET, Goo JM, Prosch H, Sverzellati N, Ciompi F, Mets OM, Gerke PK, Prokop M, van Ginneken B, Schaefer-Prokop CM |
Radiology |
2017 |
NLST |
| Lung cancer risk in welders and foundry workers with a history of heavy smoking in the USA: The National Lung Screening Trial |
|
Jason Y Y Wong, Bryan A Bassig, Wei Jie Seow, Wei Hu, Bu-Tian Ji, Aaron Blair, Debra T Silverman, Qing Lan |
Occup Environ Med |
2017 |
NLST |
| Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial. |
28424361
|
Pompe E, de Jong PA, Lynch DA, Lessmann N, Išgum I, van Ginneken B, Lammers JJ, Mohamed Hoesein FAA |
Eur. Respir. J. |
2017 |
NLST |
| Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. |
28050695
|
Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR, Aberle DR |
Eur Radiol |
2017 |
NLST |
| Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. |
28439653
|
Chung K, Jacobs C, Scholten ET, Mets OM, Dekker I, Prokop M, van Ginneken B, Schaefer-Prokop CM |
Eur Radiol |
2017 |
NLST |
| The Potential Clinical, Resource Use, And Fiscal Impacts of Lung-Rads To Inform Lung Cancer Screening In Medicare |
|
J. Roth, S.D. Sullivan, S. Ramsey, B. Goulart |
Val Health |
2016 |
NLST |
| CANARY Risk Management of Adenocarcinoma: The Future of Imaging? |
|
Finbar Foley
Srinivasan Rajagopalan
Sushravya M. Raghunath
Jennifer M. Boland
Ronald A. Karwoski
Fabien Maldonado
Brian J. Bartholmai
Tobias Peikert
|
j.semtcsv |
2016 |
NLST |
| Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules. |
27378239
|
Yip R, Yankelevitz DF, Hu M, Li K, Xu DM, Jirapatnakul A, Henschke CI |
Radiology |
2016 |
NLST |
| Evaluating Long-Term Outcomes via Computed Tomography in Lung Cancer Screening |
|
Dongfeng Wu, Ruiqi Liu, Beth Levitt, Tom Riley, Kathy B. Baumgartner |
J Biom Biostat |
2016 |
NLST |
| Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network. |
27664507
|
Petousis P, Han SX, Aberle D, Bui AA |
Artif Intell Med |
2016 |
NLST |
| Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. |
27387658
|
Balekian AA, Tanner NT, Fisher JM, Silvestri GA, Gould MK |
Ann Am Thorac Soc |
2016 |
NLST |
| A Bayesian model for estimating multi-state disease progression. |
28038345
|
Shen S, Han SX, Petousis P, Weiss RE, Meng F, Bui AA, Hsu W |
Comput. Biol. Med. |
2016 |
NLST |
| Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration. |
27330355
|
Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC |
Curr Oncol |
2016 |
NLST |
| Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. |
27179989
|
Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK |
JAMA |
2016 |
NLST |
| Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? |
27006427
|
Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB |
Clin Trials |
2016 |
NLST |
| The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort. |
27740906
|
White CS, Dharaiya E, Campbell E, Boroczky L |
Radiology |
2016 |
NLST |
| Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial |
|
Barbara L. McComb, Reginald F. Munden, Fenghai Duan, Amanda A. Jain, Catherine Tuite, Caroline Chiles |
Clin Imaging |
2016 |
NLST |
| Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. |
27009070
|
Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR |
Lancet Oncol. |
2016 |
NLST |
